Previous
Poster Home
Next
Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus: Patient Characteristics, Clinical Outcomes, and Survival Implications of Autoantibodies
07:30am - 03:35pm EDT - April 5, 2024
Information
Resources
Play Recording
Abstract: JNCCN23-0675
https://jnccn.org/view/journal...
Author(s):
John Sharp, MD
, Hematology and Medical Oncology Fellow, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Tags:
Member Institution
Outcomes and Health Services Research
Display Label
Action
NCCN - ICI T1D Poster 2.29.24.pdf
Download Handout